OmniLit Acquisition Corp. (Nasdaq: OLIT) announced this afternoon that it has completed its business combination with precision optics-maker Syntec.
Shareholders already approved the transaction at a special meeting held on October 31. Over 99.9% of the votes cast on the business combination proposal were in favor of approving the business combination and all other proposals on the ballot were also approved.
In connection with the special meeting, shareholders redeemed 97.94% of the SPAC’s trust, leaving it with 296,599 shares and $3.17 million remaining post-vote. Syntec’s CEO Joe Mohr noted that the combined company expects to use the proceeds from the transaction to further facilitate the development and large-scale deployment of its new optics and photonics products.
Starting on November 8, Syntec’s common stock and warrants are expected to trade on the Nasdaq under the symbols “OPTX” and “OPTXW,” respectively. The combined company will operate under the name Syntec Optics Holdings, Inc.
OmniLit inked the $316 million deal with Syntec in May. Rochester, New York-based Syntec provides lenses and other optical equipment to the defense, medical and consumer sectors.
The company will continue to be led by Joe Mohr, CEO, alongside the rest of the current Syntec management team.
FTAC Emerald (NASDAQ:EMLD) has entered into a definitive agreement to combine with crypto fintech firm Fold at an enterprise value of $381 million. Phoenix, Arizona-based Fold provides digital banking services backed by a treasury of Bitcoin that includes FDIC-secured checking accounts as well Bitcoin trading and awards. The combined company is expected to trade on...
At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...
Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...
At the SPAC of Dawn A new ripple is expected to come to the market today in the form of Ethereum spot ETFs after the SEC gave final approval to several yesterday. BlackRock, Fidelity, Bitwise, Franklin, and VanEck all received approval for their new funds and all but BlackRock plan to waive fees until they...